William M. Jarvis

Bill Jarvis is a Chief Chemical Engineer at CRB and has been involved with some of the most revolutionary projects in large-scale oligonucleotides production facilities worldwide. He served as the Lead Process Designer for 10 large-scale oligonucleotide and peptide synthesis facility design efforts. He has more than 42 years of broad-based chemical engineering experience, including 15 years of research related to chemical process development and optimization. His involvement ranges from exploratory process development, through lab and pilot plant scale-up, process design, process start-up and process optimization. He specializes in active pharmaceutical ingredient (API) production facility design. Bill’s diverse experience also includes design background in oral solid dose formulation (OSD), parenteral pharmaceutical formulation and filling, plasma fractionation, ADC manufacturing, biotech and protein purification projects. His involvement spans more than 300 significant drug manufacturing facility design projects.
<br/><br/>
Bill belongs to International Society for Pharmaceutical Engineering (ISPE), American Institute of Chemical Engineers (AIChE) and American Chemical Society (ACS). Bill helped with the develop the community of practice (COP) concept within the ISPE, is a past chair of the API COP, is a long term member of the containment COP and contributes to the OSD COP. He has been a guest speaker for both ISPE local chapters and national meetings, and is a past speaker for the TIDES conference on peptides and oligonucleotides.